{
  "Symbol": "RVTY",
  "AssetType": "Common Stock",
  "Name": "Revvity Inc.",
  "Description": "Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham, Massachusetts.",
  "CIK": "31791",
  "Exchange": "NYSE",
  "Currency": "USD",
  "Country": "USA",
  "Sector": "LIFE SCIENCES",
  "Industry": "LABORATORY ANALYTICAL INSTRUMENTS",
  "Address": "940 WINTER STREET, WALTHAM, MA, US",
  "OfficialSite": "https://www.revvity.com",
  "FiscalYearEnd": "December",
  "LatestQuarter": "2024-12-31",
  "MarketCapitalization": "11031925000",
  "EBITDA": "837635000",
  "PERatio": "39.03",
  "PEGRatio": "0.636",
  "BookValue": "63.55",
  "DividendPerShare": "0.28",
  "DividendYield": "0.0031",
  "EPS": "2.3",
  "RevenuePerShareTTM": "22.44",
  "ProfitMargin": "0.0981",
  "OperatingMarginTTM": "0.187",
  "ReturnOnAssetsTTM": "0.0197",
  "ReturnOnEquityTTM": "0.0364",
  "RevenueTTM": "2755026000",
  "GrossProfitTTM": "1537659000",
  "DilutedEPSTTM": "2.3",
  "QuarterlyEarningsGrowthYOY": "0.219",
  "QuarterlyRevenueGrowthYOY": "0.048",
  "AnalystTargetPrice": "132.55",
  "AnalystRatingStrongBuy": "4",
  "AnalystRatingBuy": "9",
  "AnalystRatingHold": "7",
  "AnalystRatingSell": "0",
  "AnalystRatingStrongSell": "0",
  "TrailingPE": "39.03",
  "ForwardPE": "18.15",
  "PriceToSalesRatioTTM": "4.004",
  "PriceToBookRatio": "1.407",
  "EVToRevenue": "4.7",
  "EVToEBITDA": "15.41",
  "Beta": "1.07",
  "52WeekHigh": "129.33",
  "52WeekLow": "88.53",
  "50DayMovingAverage": "107.55",
  "200DayMovingAverage": "115.57",
  "SharesOutstanding": "120147000",
  "DividendDate": "2025-05-09",
  "ExDividendDate": "2025-04-17",
  "Last Updated": "2025-04-23 14:46:02",
  "Price_Day_1": 92.33,
  "Price_Day_2": 89.77,
  "Price_Day_3": 91.82,
  "Price_Day_4": 93.6785830884754,
  "Price_Day_5": 95.467219501578,
  "Price_Day_6": 97.5456349983676,
  "Price_Day_7": 94.7877375122429,
  "Income_totalRevenue_Q1": "729372000",
  "Income_grossProfit_Q1": "412290000",
  "Income_netIncome_Q1": "94645000",
  "Income_totalRevenue_Q2": "684049000",
  "Income_grossProfit_Q2": "384816000",
  "Income_netIncome_Q2": "93386000",
  "Income_totalRevenue_Q3": "691685000",
  "Income_grossProfit_Q3": "385506000",
  "Income_netIncome_Q3": "79109000",
  "Income_totalRevenue_Q4": "649920000",
  "Income_grossProfit_Q4": "263809000",
  "Income_netIncome_Q4": "26013000",
  "Balance_totalAssets_Q1": "12392478000",
  "Balance_totalLiabilities_Q1": "4725604000",
  "Balance_totalShareholderEquity_Q1": "7666874000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q1": "1163396000",
  "Balance_totalAssets_Q2": "12769737000",
  "Balance_totalLiabilities_Q2": "4848036000",
  "Balance_totalShareholderEquity_Q2": "7921701000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q2": "1229778000",
  "Balance_totalAssets_Q3": "13424849000",
  "Balance_totalLiabilities_Q3": "5554535000",
  "Balance_totalShareholderEquity_Q3": "7870314000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q3": "1248120000",
  "Balance_totalAssets_Q4": "13432705000",
  "Balance_totalLiabilities_Q4": "5586209000",
  "Balance_totalShareholderEquity_Q4": "7846496000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q4": "999465000",
  "Debt to Equity Ratio": 0.62,
  "Is Complete": true
}